592 followers
Characterization of Poor Visual Outcomes of Neovascular #AMD Treated with Anti–Vascular Endothelial Growth Factor Agents @AAOjournal | #ECM https://t.co/83tYLlnV0d
Characterization of Poor Visual Outcomes of Neovascular #AMD Treated with Anti–Vascular Endothelial Growth Factor Agents @AAOjournal | #ECM https://t.co/83tYLlnV0d
RT @AAOjournal: Of 1760 eyes in total & 856 eyes with 5 y follow-up: 23% with nAMD developed sustained VA loss of ≥15 letters over 5 y of a…
"RT surgeonretina: Report from: SydneySaveSight USydFHS Sydney_Uni CHU_Montpellier Inserm NepeanEye nhmrc RANZCOeyedoctor maculardisease Novartis Bayer #LI https://t.co/ULEekh7l1s"